MOGADON

This brand name is authorized in Austria, Australia, Canada, France, Ireland, Malta, United Kingdom

Active ingredients

The drug MOGADON contains one active pharmaceutical ingredient (API):

1 Nitrazepam
UNII 9CLV70W7HS - NITRAZEPAM

Nitrazepam is a benzodiazepine compound with sedative properties. It acts in 30 to 60 minutes to produce sleep lasting 6 to 8 hours.

Read about Nitrazepam

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MOGADON Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05CD02 Nitrazepam N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2723H, 2732T, 5189D, 5359C
Country: CA Health Products and Food Branch Identifier(s): 00511528, 00511536
Country: FR Base de donnรฉes publique des mรฉdicaments Identifier(s): 66205536
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 16308
Country: IE Health Products Regulatory Authority Identifier(s): 71455
Country: MT Medicines Authority Identifier(s): MA1507/01601

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.